@UNPUBLISHED{Zhang2020-vr,
  title    = "Local genetic correlation analysis reveals heterogeneous
              etiologic sharing of complex traits",
  author   = "Zhang, Yiliang and Lu, Qiongshi and Ye, Yixuan and Huang, Kunling
              and Liu, Wei and Wu, Yuchang and Zhong, Xiaoyuan and Li, Boyang
              and Yu, Zhaolong and Travers, Brittany G and Werling, Donna M and
              Li, James J and Zhao, Hongyu",
  abstract = "Local genetic correlation quantifies the genetic similarity of
              complex traits in specific genomic regions, which could shed
              unique light on etiologic sharing and provide additional
              mechanistic insights into the genetic basis of complex traits
              compared to global genetic correlation. However, accurate
              estimation of local genetic correlation remains challenging, in
              part due to extensive linkage disequilibrium in local genomic
              regions and pervasive sample overlap across studies. We introduce
              SUPERGNOVA, a unified framework to estimate both global and local
              genetic correlations using summary statistics from genome-wide
              association studies. Through extensive simulations and analyses
              of 30 complex traits, we demonstrate that SUPERGNOVA
              substantially outperforms existing methods and identifies 150
              trait pairs with significant local genetic correlations. In
              particular, we show that the positive, consistently-identified,
              yet paradoxical genetic correlation between autism spectrum
              disorder and cognitive performance could be explained by two
              etiologically-distinct genetic signatures with bidirectional
              local genetic correlations. We believe that
              statistically-rigorous local genetic correlation analysis could
              accelerate progress in complex trait genetics research. \#\#\#
              Competing Interest Statement The authors have declared no
              competing interest.",
  journal  = "bioRxiv",
  pages    = "2020.05.08.084475",
  month    =  may,
  year     =  2020,
  url      = "https://www.biorxiv.org/content/10.1101/2020.05.08.084475v1.full",
  keywords = "1\_reading\_list",
  language = "en",
  doi      = "10.1101/2020.05.08.084475"
}

@ARTICLE{Lewis2021-wf,
  title     = "Spatial omics and multiplexed imaging to explore cancer biology",
  author    = "Lewis, Sabrina M and Asselin-Labat, Marie-Liesse and Nguyen,
               Quan and Berthelet, Jean and Tan, Xiao and Wimmer, Verena C and
               Merino, Delphine and Rogers, Kelly L and Naik, Shalin H",
  abstract  = "Understanding intratumoral heterogeneity---the molecular
               variation among cells within a tumor---promises to address
               outstanding questions in cancer biology and improve the
               diagnosis and treatment of specific cancer subtypes. Single-cell
               analyses, especially RNA sequencing and other genomics
               modalities, have been transformative in revealing novel
               biomarkers and molecular regulators associated with tumor
               growth, metastasis and drug resistance. However, these
               approaches fail to provide a complete picture of tumor biology,
               as information on cellular location within the tumor
               microenvironment is lost. New technologies leveraging
               multiplexed fluorescence, DNA, RNA and isotope labeling enable
               the detection of tens to thousands of cancer subclones or
               molecular biomarkers within their native spatial context. The
               expeditious growth in these techniques, along with methods for
               multiomics data integration, promises to yield a more
               comprehensive understanding of cell-to-cell variation within and
               between individual tumors. Here we provide the current state and
               future perspectives on the spatial technologies expected to
               drive the next generation of research and diagnostic and
               therapeutic strategies for cancer. This Review describes spatial
               omics and multiplexed imaging technologies and their current and
               future impact in studying tumor heterogeneity and cancer
               biology.",
  journal   = "Nat. Methods",
  publisher = "Nature Publishing Group",
  pages     = "1--16",
  month     =  aug,
  year      =  2021,
  url       = "https://www.nature.com/articles/s41592-021-01203-6",
  keywords  = "1\_reading\_list",
  language  = "en",
  issn      = "1548-7091",
  doi       = "10.1038/s41592-021-01203-6"
}

@ARTICLE{Kanai2021-lj,
  title     = "Insights from complex trait fine-mapping across diverse
               populations",
  author    = "Kanai, Masahiro and Ulirsch, Jacob C and Karjalainen, Juha and
               Kurki, Mitja and Karczewski, Konrad J and Fauman, Eric and Wang,
               Qingbo S and Jacobs, Hannah and Aguet, Fran{\c c}ois and Ardlie,
               Kristin G and Kerimov, Nurlan and Alasoo, Kaur and Benner,
               Christian and Ishigaki, Kazuyoshi and Sakaue, Saori and Reilly,
               Steven and {The BioBank Japan Project} and {FinnGen} and
               Kamatani, Yoichiro and Matsuda, Koichi and Palotie, Aarno and
               Neale, Benjamin M and Tewhey, Ryan and Sabeti, Pardis C and
               Okada, Yukinori and Daly, Mark J and Finucane, Hilary K",
  abstract  = "Despite the great success of genome-wide association studies
               (GWAS) in identifying genetic loci significantly associated with
               diseases, the vast majority of causal variants underlying
               disease-associated loci have not been identified[1][1]--[3][2].
               To create an atlas of causal variants, we performed and
               integrated fine-mapping across 148 complex traits in three
               large-scale biobanks (BioBank Japan[4][3],[5][4], FinnGen[6][5],
               and UK Biobank[7][6],[8][7]; total n = 811,261), resulting in
               4,518 variant-trait pairs with high posterior probability (>
               0.9) of causality. Of these, we found 285 high-confidence
               variant-trait pairs replicated across multiple populations, and
               we characterized multiple contributors to the surprising lack of
               overlap among fine-mapping results from different biobanks. By
               studying the bottlenecked Finnish and Japanese populations, we
               identified 21 and 26 putative causal coding variants with
               extreme allele frequency enrichment (> 10-fold) in these two
               populations, respectively. Aggregating data across populations
               enabled identification of 1,492 unique fine-mapped coding
               variants and 176 genes in which multiple independent coding
               variants influence the same trait ( i.e. , with an allelic
               series of coding variants). Our results demonstrate that
               fine-mapping in diverse populations enables novel insights into
               the biology of complex traits by pinpointing high-confidence
               causal variants for further characterization. \#\#\# Competing
               Interest Statement J.C.U. has received compensation for
               consulting from Goldfinch Bio and is an employee of Patch
               Biosciences. K.J.K is a consultant for Vor Biopharma. B.M.N. is
               a member of the scientific advisory board at Deep Genomics and
               consultant for Camp4 Therapeutics, Takeda Pharmaceutical, and
               Biogen. P.C.S. is a cofounder of and consultant to Sherlock
               Biosciences and board member of the Danaher Corporation. M.J.D.
               is a founder of Maze Therapeutics. All other authors declare no
               competing interests. \#\#\# Funding Statement This study was
               supported as an ENCODE Functional Characterization Center
               (UM1HG009435). The BioBank Japan Project was supported by the
               Tailor-Made Medical Treatment program of the Ministry of
               Education, Culture, Sports, Science, and Technology (MEXT), the
               Japan Agency for Medical Research and Development (AMED). The
               FinnGen project is funded by two grants from Business Finland
               (HUS 4685/31/2016 and UH 4386/31/2016) and the following
               industry partners: AbbVie Inc., AstraZeneca UK Ltd, Biogen MA
               Inc., Celgene Corporation, Celgene International II S{\`a}rl,
               Genentech Inc., Merck Sharp \& Dohme Corp, Pfizer Inc.,
               GlaxoSmithKline Intellectual Property Development Ltd., Sanofi
               US Services Inc., Maze Therapeutics Inc., Janssen Biotech Inc,
               and Novartis AG. Following biobanks are acknowledged for
               delivering biobank samples to FinnGen: Auria Biobank
               (www.auria.fi/biopankki), THL Biobank (www.thl.fi/biobank),
               Helsinki Biobank (www.helsinginbiopankki.fi), Biobank Borealis
               of Northern Finland
               (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki/Pages/Biobank-Borealis-briefly-in-English.aspx),
               Finnish Clinical Biobank Tampere
               (www.tays.fi/en-US/Research\textbackslash\_and\textbackslash\_development/Finnish\textbackslash\_Clinical\textbackslash\_Biobank\_Tampere),
               Biobank of Eastern Finland (www.ita-suomenbiopankki.fi/en),
               Central Finland Biobank
               (www.ksshp.fi/fi-FI/Potilaalle/Biopankki), Finnish Red Cross
               Blood Service Biobank
               (www.veripalvelu.fi/verenluovutus/biopankkitoiminta) and
               Terveystalo Biobank
               (www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/).
               All Finnish Biobanks are members of BBMRI.fi infrastructure
               (www.bbmri.fi). Finnish Biobank Cooperative -FINBB
               (https://finbb.fi/) is the coordinator of BBMRI-ERIC operations
               in Finland. M.Kanai was supported by a Nakajima Foundation
               Fellowship and the Masason Foundation. Y.O. was supported by the
               Japan Society for the Promotion of Science (JSPS) KAKENHI
               (19H01021, 20K21834), and AMED (JP20km0405211, JP20ek0109413,
               JP20ek0410075, JP20gm4010006, and JP20km0405217), Takeda Science
               Foundation, and Bioinformatics Initiative of Osaka University
               Graduate School of Medicine, Osaka University. H.K.F. was funded
               by NIH grant DP5 OD024582 and by Eric and Wendy Schmidt. \#\#\#
               Author Declarations I confirm all relevant ethical guidelines
               have been followed, and any necessary IRB and/or ethics
               committee approvals have been obtained. Yes The details of the
               IRB/oversight body that provided approval or exemption for the
               research described are given below: Written informed consent was
               obtained from all the participants in BioBank Japan, as approved
               by the ethics committees of the RIKEN Center for Integrative
               Medical Sciences, and the Institute of Medical Sciences, the
               University of Tokyo. Patients and control subjects in FinnGen
               provided informed consent for biobank research, based on the
               Finnish Biobank Act. Alternatively, separate research cohorts,
               collected prior the Finnish Biobank Act came into effect (in
               September 2013) and start of FinnGen (August 2017), were
               collected based on study-specific consents and later transferred
               to the Finnish biobanks after approval by Fimea, the National
               Supervisory Authority for Welfare and Health. Recruitment
               protocols followed the biobank protocols approved by Fimea. The
               Coordinating Ethics Committee of the Hospital District of
               Helsinki and Uusimaa (HUS) approved the FinnGen study protocol
               Nr HUS/990/2017. The FinnGen study is approved by Finnish
               Institute for Health and Welfare (permit numbers:
               THL/2031/6.02.00/2017, THL/1101/5.05.00/2017,
               THL/341/6.02.00/2018, THL/2222/6.02.00/2018,
               THL/283/6.02.00/2019, THL/1721/5.05.00/2019,
               THL/1524/5.05.00/2020, and THL/2364/14.02/2020), Digital and
               population data service agency (permit numbers: VRK43431/2017-3,
               VRK/6909/2018-3, VRK/4415/2019-3), the Social Insurance
               Institution (permit numbers: KELA 58/522/2017, KELA
               131/522/2018, KELA 70/522/2019, KELA 98/522/2019, KELA
               138/522/2019, KELA 2/522/2020, KELA 16/522/2020 and Statistics
               Finland (permit numbers: TK-53-1041-17 and TK-53-90-20). The
               Biobank Access Decisions for FinnGen samples and data utilized
               in FinnGen Data Freeze 6 include: THL Biobank
               BB2017\textbackslash\_55, BB2017\textbackslash\_111,
               BB2018\textbackslash\_19,
               BB\textbackslash\_2018\textbackslash\_34,
               BB\textbackslash\_2018\textbackslash\_67,
               BB2018\textbackslash\_71, BB2019\textbackslash\_7,
               BB2019\textbackslash\_8, BB2019\textbackslash\_26,
               BB2020\textbackslash\_1, Finnish Red Cross Blood Service Biobank
               7.12.2017, Helsinki Biobank HUS/359/2017, Auria Biobank
               AB17-5154, Biobank Borealis of Northern
               Finland\textbackslash\_2017\textbackslash\_1013, Biobank of
               Eastern Finland 1186/2018, Finnish Clinical Biobank Tampere
               MH0004, Central Finland Biobank 1-2017, and Terveystalo Biobank
               STB 2018001. All Finnish Biobanks are members of BBMRI.fi
               infrastructure (www.bbmri.fi). Finnish Biobank Cooperative
               -FINBB (https://finbb.fi/) is the coordinator of BBMRI-ERIC
               operations in Finland. All necessary patient/participant consent
               has been obtained and the appropriate institutional forms have
               been archived. Yes I understand that all clinical trials and any
               other prospective interventional studies must be registered with
               an ICMJE-approved registry, such as ClinicalTrials.gov. I
               confirm that any such study reported in the manuscript has been
               registered and the trial registration ID is provided (note: if
               posting a prospective study registered retrospectively, please
               provide a statement in the trial ID field explaining why the
               study was not registered in advance). Yes I have followed all
               appropriate research reporting guidelines and uploaded the
               relevant EQUATOR Network research reporting checklist(s) and
               other pertinent material as supplementary files, if applicable.
               Yes The fine-mapping results produced by this study will be
               publicly available at https://www.finucanelab.org/data. The BBJ
               summary statistics are available at the National Bioscience
               Database Center (NBDC) Human Database (accession code: hum0197)
               and at the GWAS catalog69 (https://www.ebi.ac.uk/gwas/home).
               They are also browsable at our PheWeb website
               (https://pheweb.jp/). The BBJ genotype data is accessible on
               request at the Japanese Genotype-phenotype Archive
               (http://trace.ddbj.nig.ac.jp/jga/index\textbackslash\_e.html)
               with accession code JGAD00000000123 and JGAS00000000114. The
               UKBB summary statistics will be available at the ENCODE data
               portal (https://www.encodeproject.org/) and at the GWAS catalog
               (https://www.ebi.ac.uk/gwas/home). The UKBB individual-level
               data is accessible on request through the UK Biobank Access
               Management System (https://www.ukbiobank.ac.uk/). The UKBB
               analysis in this study was conducted via application number
               31063. The FinnGen release 6 was used in this study and is still
               subject to embargo according to the FinnGen consortium
               agreement; thus the FinnGen summary statistics are available on
               request
               (https://www.finngen.fi/en/access\textbackslash\_results) and
               are being prepared for public release by Q4 2021. The GTEx v8
               summary statistics is available at the GTEx Portal
               (https://gtexportal.org/home/datasets). The GTEx
               individual-level data is accessible on request through the dbGAP
               application (accession code: phs000424.v8.p2;
               https://gtexportal.org/home/protectedDataAccess). The eQTL
               catalogue results are available at
               https://www.ebi.ac.uk/eqtl/Data\_access/. [1]: \#ref-1 [2]:
               \#ref-3 [3]: \#ref-4 [4]: \#ref-5 [5]: \#ref-6 [6]: \#ref-7 [7]:
               \#ref-8",
  journal   = "medRxiv",
  publisher = "Cold Spring Harbor Laboratory Press",
  pages     = "2021.09.03.21262975",
  month     =  sep,
  year      =  2021,
  url       = "https://www.medrxiv.org/content/10.1101/2021.09.03.21262975v1.abstract",
  keywords  = "1\_reading\_list",
  language  = "en",
  doi       = "10.1101/2021.09.03.21262975"
}

@ARTICLE{Brbic2022-ik,
  title     = "Annotation of spatially resolved single-cell data with {STELLAR}",
  author    = "Brbi{\'c}, Maria and Cao, Kaidi and Hickey, John W and Tan, Yuqi
               and Snyder, Michael P and Nolan, Garry P and Leskovec, Jure",
  abstract  = "Accurate cell-type annotation from spatially resolved single
               cells is crucial to understand functional spatial biology that
               is the basis of tissue organization. However, current
               computational methods for annotating spatially resolved
               single-cell data are typically based on techniques established
               for dissociated single-cell technologies and thus do not take
               spatial organization into account. Here we present STELLAR, a
               geometric deep learning method for cell-type discovery and
               identification in spatially resolved single-cell datasets.
               STELLAR automatically assigns cells to cell types present in the
               annotated reference dataset and discovers novel cell types and
               cell states. STELLAR transfers annotations across different
               dissection regions, different tissues and different donors, and
               learns cell representations that capture higher-order tissue
               structures. We successfully applied STELLAR to CODEX multiplexed
               fluorescent microscopy data and multiplexed RNA imaging
               datasets. Within the Human BioMolecular Atlas Program, STELLAR
               has annotated 2.6 million spatially resolved single cells with
               dramatic time savings. STELLAR (spatial cell learning) is a
               geometric deep learning model that works with spatially resolved
               single-cell datasets to both assign cell types in unannotated
               datasets based on a reference dataset and discover new cell
               types.",
  journal   = "Nat. Methods",
  publisher = "Nature Publishing Group",
  pages     = "1--8",
  month     =  oct,
  year      =  2022,
  url       = "https://www.nature.com/articles/s41592-022-01651-8",
  keywords  = "1\_reading\_list",
  language  = "en",
  issn      = "1548-7091",
  doi       = "10.1038/s41592-022-01651-8"
}

@ARTICLE{Berg2019-ub,
  title       = "ilastik: interactive machine learning for (bio)image analysis",
  author      = "Berg, Stuart and Kutra, Dominik and Kroeger, Thorben and
                 Straehle, Christoph N and Kausler, Bernhard X and Haubold,
                 Carsten and Schiegg, Martin and Ales, Janez and Beier,
                 Thorsten and Rudy, Markus and Eren, Kemal and Cervantes, Jaime
                 I and Xu, Buote and Beuttenmueller, Fynn and Wolny, Adrian and
                 Zhang, Chong and Koethe, Ullrich and Hamprecht, Fred A and
                 Kreshuk, Anna",
  affiliation = "HHMI Janelia Research Campus, Ashburn, Virginia, USA. HCI/IWR,
                 Heidelberg University, Heidelberg, Germany. European Molecular
                 Biology Laboratory, Heidelberg, Germany. HCI/IWR, Heidelberg
                 University, Heidelberg, Germany.
                 fred.hamprecht@iwr.uni-heidelberg.de. HCI/IWR, Heidelberg
                 University, Heidelberg, Germany. anna.kreshuk@embl.de.
                 European Molecular Biology Laboratory, Heidelberg, Germany.
                 anna.kreshuk@embl.de.",
  abstract    = "We present ilastik, an easy-to-use interactive tool that
                 brings machine-learning-based (bio)image analysis to end users
                 without substantial computational expertise. It contains
                 pre-defined workflows for image segmentation, object
                 classification, counting and tracking. Users adapt the
                 workflows to the problem at hand by interactively providing
                 sparse training annotations for a nonlinear classifier.
                 ilastik can process data in up to five dimensions (3D, time
                 and number of channels). Its computational back end runs
                 operations on-demand wherever possible, allowing for
                 interactive prediction on data larger than RAM. Once the
                 classifiers are trained, ilastik workflows can be applied to
                 new data from the command line without further user
                 interaction. We describe all ilastik workflows in detail,
                 including three case studies and a discussion on the expected
                 performance.",
  journal     = "Nat. Methods",
  volume      =  16,
  number      =  12,
  pages       = "1226--1232",
  month       =  dec,
  year        =  2019,
  url         = "http://dx.doi.org/10.1038/s41592-019-0582-9",
  keywords    = "1\_reading\_list",
  language    = "en",
  issn        = "1548-7091, 1548-7105",
  pmid        = "31570887",
  doi         = "10.1038/s41592-019-0582-9"
}

@ARTICLE{Leuschner2010-wz,
  title       = "Angiotensin-converting enzyme inhibition prevents the release
                 of monocytes from their splenic reservoir in mice with
                 myocardial infarction",
  author      = "Leuschner, Florian and Panizzi, Peter and Chico-Calero, Isabel
                 and Lee, Won Woo and Ueno, Takuya and Cortez-Retamozo, Virna
                 and Waterman, Peter and Gorbatov, Rostic and Marinelli, Brett
                 and Iwamoto, Yoshiko and Chudnovskiy, Aleksey and Figueiredo,
                 Jose-Luiz and Sosnovik, David E and Pittet, Mikael J and
                 Swirski, Filip K and Weissleder, Ralph and Nahrendorf,
                 Matthias",
  affiliation = "Center for Systems Biology, Massachusetts General Hospital and
                 Harvard Medical School, USA.",
  abstract    = "RATIONALE: Monocytes recruited to ischemic myocardium
                 originate from a reservoir in the spleen, and the release from
                 their splenic niche relies on angiotensin (Ang) II signaling.
                 OBJECTIVE: Because monocytes are centrally involved in tissue
                 repair after ischemia, we hypothesized that early
                 angiotensin-converting enzyme (ACE) inhibitor therapy impacts
                 healing after myocardial infarction partly via effects on
                 monocyte traffic. METHODS AND RESULTS: In a mouse model of
                 permanent coronary ligation, enalapril arrested the release of
                 monocytes from the splenic reservoir and consequently reduced
                 their recruitment into the healing infarct by 45\%, as
                 quantified by flow cytometry of digested infarcts. Time-lapse
                 intravital microscopy revealed that enalapril reduces monocyte
                 motility in the spleen. In vitro migration assays and Western
                 blotting showed that this was caused by reduced signaling
                 through the Ang II type 1 receptor. We then studied the
                 long-term consequences of blocked splenic monocyte release in
                 atherosclerotic apolipoprotein (apo)E(-/-) mice, in which
                 infarct healing is impaired because of excessive inflammation
                 in the cardiac wound. Enalapril improved histologic healing
                 biomarkers and reduced inflammation in infarcts measured by
                 FMT-CT (fluorescence molecular tomography in conjunction with
                 x-ray computed tomography) of proteolytic activity. ACE
                 inhibition improved MRI-derived ejection fraction by 14\% on
                 day 21, despite initially comparable infarct size. In
                 apoE(-/-) mice, ischemia/reperfusion injury resulted in larger
                 infarct size and enhanced monocyte recruitment and was
                 reversible by enalapril treatment. Splenectomy reproduced
                 antiinflammatory effects of enalapril. CONCLUSION: This study
                 suggests that benefits of early ACE inhibition after
                 myocardial infarction can partially be attributed to its
                 potent antiinflammatory impact on the splenic monocyte
                 reservoir.",
  journal     = "Circ. Res.",
  volume      =  107,
  number      =  11,
  pages       = "1364--1373",
  month       =  nov,
  year        =  2010,
  url         = "http://dx.doi.org/10.1161/CIRCRESAHA.110.227454",
  keywords    = "1\_reading\_list",
  language    = "en",
  issn        = "0009-7330, 1524-4571",
  pmid        = "20930148",
  doi         = "10.1161/CIRCRESAHA.110.227454",
  pmc         = "PMC2992104"
}

@ARTICLE{Getz2016-lk,
  title       = "Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on
                 Atherogenesis?",
  author      = "Getz, Godfrey S and Reardon, Catherine A",
  affiliation = "From the Department of Pathology (G.S.G.) and Ben May
                 Institute for Cancer Biology (C.A.R.), University of Chicago,
                 IL. getz@bsd.uchicago.edu. From the Department of Pathology
                 (G.S.G.) and Ben May Institute for Cancer Biology (C.A.R.),
                 University of Chicago, IL.",
  abstract    = "Murine models of atherosclerosis are useful for investigating
                 the environmental and genetic influences on lesion formation
                 and composition. Apoe(-/-) and Ldlr(-/-) mice are the 2 most
                 extensively used models. The models differ in important ways
                 with respect to the precise mechanism by which their absence
                 enhances atherosclerosis, including differences in plasma
                 lipoproteins. The majority of the gene function studies have
                 utilized only 1 model, with the results being generalized to
                 atherogenic mechanisms. In only a relatively few cases have
                 studies been conducted in both atherogenic murine models. This
                 review will discuss important differences between the 2
                 atherogenic models and will point out studies that have been
                 performed in the 2 models where results are comparable and
                 those where different results were obtained.",
  journal     = "Arterioscler. Thromb. Vasc. Biol.",
  volume      =  36,
  number      =  9,
  pages       = "1734--1741",
  month       =  sep,
  year        =  2016,
  url         = "http://dx.doi.org/10.1161/ATVBAHA.116.306874",
  keywords    = "atherosclerosis; diet; genetic background; lipoprotein;
                 mice;1\_reading\_list",
  language    = "en",
  issn        = "1079-5642, 1524-4636",
  pmid        = "27386935",
  doi         = "10.1161/ATVBAHA.116.306874",
  pmc         = "PMC5001905"
}

@ARTICLE{Hoeft2023-vb,
  title       = "Platelet-instructed {SPP1+} macrophages drive myofibroblast
                 activation in fibrosis in a {CXCL4-dependent} manner",
  author      = "Hoeft, Konrad and Schaefer, Gideon J L and Kim, Hyojin and
                 Schumacher, David and Bleckwehl, Tore and Long, Qingqing and
                 Klinkhammer, Barbara Mara and Peisker, Fabian and Koch, Lars
                 and Nagai, James and Halder, Maurice and Ziegler, Susanne and
                 Liehn, Elisa and Kuppe, Christoph and Kranz, Jennifer and
                 Menzel, Sylvia and Costa, Ivan and Wahida, Adam and Boor,
                 Peter and Schneider, Rebekka K and Hayat, Sikander and
                 Kramann, Rafael",
  affiliation = "Division of Nephrology and Clinical Immunology, RWTH Aachen
                 University, Aachen, Germany; Institute of Experimental
                 Medicine and Systems Biology, RWTH Aachen University, Aachen,
                 Germany. Institute of Experimental Medicine and Systems
                 Biology, RWTH Aachen University, Aachen, Germany. Institute of
                 Experimental Medicine and Systems Biology, RWTH Aachen
                 University, Aachen, Germany; Department of Anesthesiology,
                 RWTH Aachen University, Aachen, Germany. Department of
                 Pathology, RWTH Aachen University, Aachen, Germany. Institute
                 for Computational Genomics, RWTH Aachen University Hospital,
                 Aachen, Germany; Joint Research Center for Computational
                 Biomedicine, RWTH Aachen University Hospital, Aachen, Germany.
                 Institute for Molecular Medicine, University of South Denmark,
                 Odense, Denmark. Institute of Experimental Medicine and
                 Systems Biology, RWTH Aachen University, Aachen, Germany;
                 Department of Urology, RWTH Aachen University, Aachen,
                 Germany; Department of Urology and Kidney Transplantation,
                 Martin-Luther-University, Halle (Saale), Germany. Institute of
                 Metabolism and Cell Death, Helmholtz Zentrum M{\"u}nchen,
                 Neuherberg, Germany; Division of Gynecological Oncology,
                 National Center for Tumor Diseases (NCT), Heidelberg, Germany.
                 Division of Nephrology and Clinical Immunology, RWTH Aachen
                 University, Aachen, Germany; Department of Pathology, RWTH
                 Aachen University, Aachen, Germany. Department of Hematology,
                 Erasmus MC Cancer Institute, Rotterdam, the Netherlands;
                 Department of Cell Biology, Institute for Biomedical
                 Technologies, RWTH Aachen University, Aachen, Germany.
                 Division of Nephrology and Clinical Immunology, RWTH Aachen
                 University, Aachen, Germany; Institute of Experimental
                 Medicine and Systems Biology, RWTH Aachen University, Aachen,
                 Germany; Department of Internal Medicine, Nephrology and
                 Transplantation, Erasmus Medical Center, Rotterdam, the
                 Netherlands. Electronic address: rkramann@gmx.net.",
  abstract    = "Fibrosis represents the common end stage of chronic organ
                 injury independent of the initial insult, destroying tissue
                 architecture and driving organ failure. Here we discover a
                 population of profibrotic macrophages marked by expression of
                 Spp1, Fn1, and Arg1 (termed Spp1 macrophages), which expands
                 after organ injury. Using an unbiased approach, we identify
                 the chemokine (C-X-C motif) ligand 4 (CXCL4) to be among the
                 top upregulated genes during profibrotic Spp1 macrophage
                 differentiation. In vitro and in vivo studies show that loss
                 of Cxcl4 abrogates profibrotic Spp1 macrophage differentiation
                 and ameliorates fibrosis after both heart and kidney injury.
                 Moreover, we find that platelets, the most abundant source of
                 CXCL4 in vivo, drive profibrotic Spp1 macrophage
                 differentiation. Single nuclear RNA sequencing with
                 ligand-receptor interaction analysis reveals that macrophages
                 orchestrate fibroblast activation via Spp1, Fn1, and Sema3
                 crosstalk. Finally, we confirm that Spp1 macrophages expand in
                 both human chronic kidney disease and heart failure.",
  journal     = "Cell Rep.",
  volume      =  42,
  number      =  2,
  pages       = "112131",
  month       =  feb,
  year        =  2023,
  url         = "http://dx.doi.org/10.1016/j.celrep.2023.112131",
  keywords    = "CP: Immunology; CXCL4; PF4; SPP1; SPP1 macrophages; chronic
                 kidney disease; fibrosis; heart failure; innate immunity;
                 myocardial infarction; platelets;1\_reading\_list",
  language    = "en",
  issn        = "2211-1247",
  pmid        = "36807143",
  doi         = "10.1016/j.celrep.2023.112131",
  pmc         = "PMC9992450"
}

@ARTICLE{Bajpai2019-yg,
  title       = "Tissue Resident {CCR2-} and {CCR2+} Cardiac Macrophages
                 Differentially Orchestrate Monocyte Recruitment and Fate
                 Specification Following Myocardial Injury",
  author      = "Bajpai, Geetika and Bredemeyer, Andrea and Li, Wenjun and
                 Zaitsev, Konstantin and Koenig, Andrew L and Lokshina, Inessa
                 and Mohan, Jayaram and Ivey, Brooke and Hsiao, His-Min and
                 Weinheimer, Carla and Kovacs, Attila and Epelman, Slava and
                 Artyomov, Maxim and Kreisel, Daniel and Lavine, Kory J",
  affiliation = "From the Department of Medicine (G.B., A.B., A.L. Koenig,
                 I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington
                 University School of Medicine, St. Louis, MO. Department of
                 Surgery (W.L., H.-M.H., D.K., K.J.L.), Washington University
                 School of Medicine, St. Louis, MO. Department of Immunology
                 and Pathology (K.Z., M.A., D.K., K.J.L.), Washington
                 University School of Medicine, St. Louis, MO. Toronto General
                 Hospital Research Institute, Division of Cardiology,
                 University Health Network, ON, Canada (S.E.). Department of
                 Developmental Biology (K.J.L.), Washington University School
                 of Medicine, St. Louis, MO.",
  abstract    = "RATIONALE: Recent advancements have brought to light the
                 origins, complexity, and functions of tissue-resident
                 macrophages. However, in the context of tissue injury or
                 disease, large numbers of monocytes infiltrate the heart and
                 are thought to contribute to adverse remodeling and heart
                 failure pathogenesis. Little is understood about the diversity
                 of monocytes and monocyte-derived macrophages recruited to the
                 heart after myocardial injury, including the mechanisms that
                 regulate monocyte recruitment and fate specification.
                 OBJECTIVE: We sought to test the hypothesis that distinct
                 subsets of tissue-resident CCR2- (C-C chemokine receptor 2)
                 and CCR2+ macrophages orchestrate monocyte recruitment and
                 fate specification after myocardial injury. METHODS AND
                 RESULTS: We reveal that in numerous mouse models of
                 cardiomyocyte cell death (permanent myocardial infarction,
                 reperfused myocardial infarction, and diphtheria toxin
                 cardiomyocyte ablation), there is a shift in macrophage
                 ontogeny whereby tissue-resident macrophages are predominately
                 replaced by infiltrating monocytes and monocyte-derived
                 macrophages. Using syngeneic cardiac transplantation to model
                 ischemia-reperfusion injury and distinguish tissue-resident
                 from recruited cell populations in combination with intravital
                 2-photon microscopy, we demonstrate that monocyte recruitment
                 is differentially orchestrated by distinct subsets of
                 tissue-resident cardiac macrophages. Tissue-resident CCR2+
                 macrophages promote monocyte recruitment through an MYD88
                 (myeloid differentiation primary response 88)-dependent
                 mechanism that results in release of MCPs (monocyte
                 chemoattractant proteins) and monocyte mobilization. In
                 contrast, tissue-resident CCR2- macrophages inhibit monocyte
                 recruitment. Using CD (cluster of differentiation) 169-DTR
                 (diphtheria toxin receptor) and CCR2-DTR mice, we further show
                 that selective depletion of either tissue-resident CCR2- or
                 CCR2+ macrophages before myocardial infarction results in
                 divergent effects on left ventricular function, myocardial
                 remodeling, and monocyte recruitment. Finally, using
                 single-cell RNA sequencing, we show that tissue-resident
                 cardiac macrophages differentially instruct monocyte fate
                 specification. CONCLUSIONS: Collectively, these observations
                 establish the mechanistic basis by which monocytes are
                 initially recruited to the injured heart and provide new
                 insights into the heterogeneity of monocyte-derived
                 macrophages.",
  journal     = "Circ. Res.",
  volume      =  124,
  number      =  2,
  pages       = "263--278",
  month       =  jan,
  year        =  2019,
  url         = "http://dx.doi.org/10.1161/CIRCRESAHA.118.314028",
  keywords    = "inflammation; macrophages; monocytes; myocardial infarction;
                 receptors, CCR2;Myocardial infarction;1\_reading\_list",
  language    = "en",
  issn        = "0009-7330, 1524-4571",
  pmid        = "30582448",
  doi         = "10.1161/CIRCRESAHA.118.314028",
  pmc         = "PMC6626616"
}

@ARTICLE{Ward2022-ga,
  title       = "An image analysis protocol using {CellProfiler} for automated
                 quantification of post-ischemic cardiac parameters",
  author      = "Ward, Alexander O and Janbandhu, Vaibhao and Chapman, Gavin
                 and Dunwoodie, Sally L and Harvey, Richard P",
  affiliation = "Victor Chang Cardiac Research Institute, Darlinghurst, NSW,
                 Australia. St. Vincent's Clinical School, UNSW Sydney, Sydney,
                 NSW, Australia. School of Biotechnology and Biomolecular
                 Science, UNSW Sydney, Sydney, NSW, Australia.",
  abstract    = "Quantitative assessment of post-ischemic cardiac remodeling is
                 often hampered by tissue complexity and structural
                 heterogeneity of the scar. Automated quantification of
                 microscopy images offers an unbiased approach to reduce
                 inter-observer variability. Here, we present a
                 CellProfiler-based analytical pipeline for the high-throughput
                 analysis of confocal images to quantify post-ischemic cardiac
                 parameters. We describe image preprocessing and the
                 quantification of capillary rarefaction, immune cell
                 infiltration, cell death, and proliferating fibroblasts. This
                 protocol can be adapted to other tissue types. For complete
                 details on the use and execution of this profile, please refer
                 to Janbandhu et al. (2021).",
  journal     = "STAR Protoc",
  volume      =  3,
  number      =  1,
  pages       = "101097",
  month       =  mar,
  year        =  2022,
  url         = "http://dx.doi.org/10.1016/j.xpro.2021.101097",
  keywords    = "Cell Biology; Computer sciences; Microscopy;Myocardial
                 infarction;1\_reading\_list",
  language    = "en",
  issn        = "2666-1667",
  pmid        = "35535162",
  doi         = "10.1016/j.xpro.2021.101097",
  pmc         = "PMC9076969"
}

@ARTICLE{Zhang2022-hn,
  title       = "Identification of cell types in multiplexed in situ images by
                 combining protein expression and spatial information using
                 {CELESTA}",
  author      = "Zhang, Weiruo and Li, Irene and Reticker-Flynn, Nathan E and
                 Good, Zinaida and Chang, Serena and Samusik, Nikolay and
                 Saumyaa, Saumyaa and Li, Yuanyuan and Zhou, Xin and Liang,
                 Rachel and Kong, Christina S and Le, Quynh-Thu and Gentles,
                 Andrew J and Sunwoo, John B and Nolan, Garry P and Engleman,
                 Edgar G and Plevritis, Sylvia K",
  affiliation = "Department of Biomedical Data Science, School of Medicine,
                 Stanford University, Stanford, CA, USA. Department of
                 Radiology, School of Medicine, Stanford University, Stanford,
                 CA, USA. Cancer Biology Program, School of Medicine, Stanford
                 University, Stanford, CA, USA. Department of Pathology, School
                 of Medicine, Stanford University, Stanford, CA, USA. Stanford
                 Cancer Institute, Stanford University, Stanford, CA, USA.
                 Division of Head and Neck Surgery, Department of
                 Otolaryngology, School of Medicine, Stanford University,
                 Stanford, CA, USA. Department of Computer Science, Stanford
                 University, Stanford, CA, USA. Department of Radiation
                 Oncology, School of Medicine, Stanford University, Stanford,
                 CA, USA. Department of Medicine, Quantitative Sciences Unit,
                 Stanford University, Stanford, CA, USA. Department of
                 Biomedical Data Science, School of Medicine, Stanford
                 University, Stanford, CA, USA. plevriti@stanford.edu.
                 Department of Radiology, School of Medicine, Stanford
                 University, Stanford, CA, USA. plevriti@stanford.edu.",
  abstract    = "Advances in multiplexed in situ imaging are revealing
                 important insights in spatial biology. However, cell type
                 identification remains a major challenge in imaging analysis,
                 with most existing methods involving substantial manual
                 assessment and subjective decisions for thousands of cells. We
                 developed an unsupervised machine learning algorithm, CELESTA,
                 which identifies the cell type of each cell, individually,
                 using the cell's marker expression profile and, when needed,
                 its spatial information. We demonstrate the performance of
                 CELESTA on multiplexed immunofluorescence images of colorectal
                 cancer and head and neck squamous cell carcinoma (HNSCC).
                 Using the cell types identified by CELESTA, we identify tissue
                 architecture associated with lymph node metastasis in HNSCC,
                 and validate our findings in an independent cohort. By
                 coupling our spatial analysis with single-cell RNA-sequencing
                 data on proximal sections of the same specimens, we identify
                 cell-cell crosstalk associated with lymph node metastasis,
                 demonstrating the power of CELESTA to facilitate
                 identification of clinically relevant interactions.",
  journal     = "Nat. Methods",
  volume      =  19,
  number      =  6,
  pages       = "759--769",
  month       =  jun,
  year        =  2022,
  url         = "http://dx.doi.org/10.1038/s41592-022-01498-z",
  keywords    = "1\_reading\_list",
  language    = "en",
  issn        = "1548-7091, 1548-7105",
  pmid        = "35654951",
  doi         = "10.1038/s41592-022-01498-z"
}

@ARTICLE{Calcagno2020-yd,
  title       = "The myeloid type {I} interferon response to myocardial
                 infarction begins in bone marrow and is regulated by
                 Nrf2-activated macrophages",
  author      = "Calcagno, David M and Ng, Jr, Richard P and Toomu, Avinash and
                 Zhang, Claire and Huang, Kenneth and Aguirre, Aaron D and
                 Weissleder, Ralph and Daniels, Lori B and Fu, Zhenxing and
                 King, Kevin R",
  affiliation = "Department of Bioengineering, Jacobs School of Engineering,
                 University of California San Diego, La Jolla, CA, USA.
                 Division of Cardiology and Cardiovascular Institute,
                 Department of Medicine, University of California San Diego, La
                 Jolla, CA, USA. Cardiology Division, Massachusetts General
                 Hospital, Harvard Medical School, Boston, MA, USA. Center for
                 Systems Biology, Massachusetts General Hospital, Harvard
                 Medical School, Boston, MA, USA. Wellman Center for
                 Photomedicine, Massachusetts General Hospital, Harvard Medical
                 School, Boston, MA, USA. Department of Bioengineering, Jacobs
                 School of Engineering, University of California San Diego, La
                 Jolla, CA, USA. krking@ucsd.edu.",
  abstract    = "Sterile tissue injury is thought to locally activate innate
                 immune responses via damage-associated molecular patterns
                 (DAMPs). Whether innate immune pathways are remotely activated
                 remains relatively unexplored. Here, by analyzing ~145,000
                 single-cell transcriptomes at steady state and after
                 myocardial infarction (MI) in mice and humans, we show that
                 the type I interferon (IFN) response, characterized by
                 expression of IFN-stimulated genes (ISGs), begins far from the
                 site of injury, in neutrophil and monocyte progenitors within
                 the bone marrow. In the peripheral blood of patients, we
                 observed defined subsets of ISG-expressing neutrophils and
                 monocytes. In the bone marrow and blood of mice, ISG
                 expression was detected in neutrophils and monocytes and their
                 progenitors, intensified with maturation at steady-state and
                 after MI, and was controlled by Tet2 and Irf3 transcriptional
                 regulators. Within the infarcted heart, ISG-expressing cells
                 were negatively regulated by Nrf2 activation in Ccr2-
                 steady-state cardiac macrophages. Our results show that IFN
                 signaling begins in the bone marrow, implicate multiple
                 transcriptional regulators (Tet2, Irf3, and Nrf2) in governing
                 ISG expression, and provide a clinical biomarker (ISG score)
                 for studying IFN signaling in patients.",
  journal     = "Sci Immunol",
  volume      =  5,
  number      =  51,
  month       =  sep,
  year        =  2020,
  url         = "http://dx.doi.org/10.1126/sciimmunol.aaz1974",
  keywords    = "Heart;1\_reading\_list",
  language    = "en",
  issn        = "2470-9468",
  pmid        = "32978242",
  doi         = "10.1126/sciimmunol.aaz1974",
  pmc         = "PMC7808338"
}

@ARTICLE{Martins-Marques2021-xc,
  title       = "Intercellular Communication in the Heart: Therapeutic
                 Opportunities for Cardiac Ischemia",
  author      = "Martins-Marques, Tania and Hausenloy, Derek J and Sluijter,
                 Joost P G and Leybaert, Luc and Girao, Henrique",
  affiliation = "Univ Coimbra, Coimbra Institute for Clinical and Biomedical
                 Research (iCBR), Faculty of Medicine, Coimbra, Portugal; Univ
                 Coimbra, Center for Innovative Biomedicine and Biotechnology
                 (CIBB), Coimbra, Portugal; Clinical Academic Centre of Coimbra
                 (CACC), Coimbra, Portugal. Cardiovascular \& Metabolic
                 Disorders Program, Duke-National University of Singapore
                 Medical School, Singapore; National Heart Research Institute
                 Singapore, National Heart Centre, Singapore; Yong Loo Lin
                 School of Medicine, National University Singapore, Singapore;
                 The Hatter Cardiovascular Institute, University College
                 London, London, UK; Cardiovascular Research Center, College of
                 Medical and Health Sciences, Asia University, Taiwan.
                 Laboratory of Experimental Cardiology, UMC Utrecht
                 Regenerative Medicine Center, Circulatory Health Laboratory,
                 University Medical Center Utrecht, University Utrecht,
                 Utrecht, The Netherlands. Department of Basic and Applied
                 Medical Sciences, Faculty of Medicine and Health Sciences,
                 Ghent University, Ghent, Belgium. Univ Coimbra, Coimbra
                 Institute for Clinical and Biomedical Research (iCBR), Faculty
                 of Medicine, Coimbra, Portugal; Univ Coimbra, Center for
                 Innovative Biomedicine and Biotechnology (CIBB), Coimbra,
                 Portugal; Clinical Academic Centre of Coimbra (CACC), Coimbra,
                 Portugal. Electronic address: hmgirao@fmed.uc.pt.",
  abstract    = "The maintenance of tissue, organ, and organism homeostasis
                 relies on an intricate network of players and mechanisms that
                 assist in the different forms of cell-cell communication.
                 Myocardial infarction, following heart ischemia and
                 reperfusion, is associated with profound changes in key
                 processes of intercellular communication, involving gap
                 junctions, extracellular vesicles, and tunneling nanotubes,
                 some of which have been implicated in communication defects
                 associated with cardiac injury, namely arrhythmogenesis and
                 progression into heart failure. Therefore, intercellular
                 communication players have emerged as attractive powerful
                 therapeutic targets aimed at preserving a fine-tuned crosstalk
                 between the different cardiac cells in order to prevent or
                 repair some of harmful consequences of heart ischemia and
                 reperfusion, re-establishing myocardial function.",
  journal     = "Trends Mol. Med.",
  volume      =  27,
  number      =  3,
  pages       = "248--262",
  month       =  mar,
  year        =  2021,
  url         = "http://dx.doi.org/10.1016/j.molmed.2020.10.002",
  keywords    = "acute myocardial infarction; cardioprotection; extracellular
                 vesicles; gap junctions; intercellular communication; remote
                 ischemic conditioning;1\_reading\_list;Heart;Myocardial
                 infarction",
  language    = "en",
  issn        = "1471-4914, 1471-499X",
  pmid        = "33139169",
  doi         = "10.1016/j.molmed.2020.10.002"
}

@ARTICLE{Gut2018-nr,
  title       = "Multiplexed protein maps link subcellular organization to
                 cellular states",
  author      = "Gut, Gabriele and Herrmann, Markus D and Pelkmans, Lucas",
  affiliation = "Institute of Molecular Life Sciences, University of Zurich,
                 Zurich, Switzerland. gabriele.gut@uzh.ch
                 lucas.pelkmans@imls.uzh.ch. Molecular Life Sciences PhD
                 Program, Life Science Zurich Graduate School, University of
                 Zurich, Zurich, Switzerland. Institute of Molecular Life
                 Sciences, University of Zurich, Zurich, Switzerland. MD-PhD
                 and Systems Biology PhD Program, Life Science Zurich Graduate
                 School, University of Zurich, Zurich, Switzerland.",
  abstract    = "Obtaining highly multiplexed protein measurements across
                 multiple length scales has enormous potential for biomedicine.
                 Here, we measured, by iterative indirect immunofluorescence
                 imaging (4i), 40-plex protein readouts from biological samples
                 at high-throughput from the millimeter to the nanometer scale.
                 This approach simultaneously captures properties apparent at
                 the population, cellular, and subcellular levels, including
                 microenvironment, cell shape, and cell cycle state. It also
                 captures the detailed morphology of organelles, cytoskeletal
                 structures, nuclear subcompartments, and the fate of signaling
                 receptors in thousands of single cells in situ. We used
                 computer vision and systems biology approaches to achieve
                 unsupervised comprehensive quantification of protein
                 subcompartmentalization within various multicellular,
                 cellular, and pharmacological contexts. Thus, highly
                 multiplexed subcellular protein maps can be used to identify
                 functionally relevant single-cell states.",
  journal     = "Science",
  volume      =  361,
  number      =  6401,
  month       =  aug,
  year        =  2018,
  url         = "http://dx.doi.org/10.1126/science.aar7042",
  keywords    = "1\_reading\_list;Highly multiplexed imaging",
  language    = "en",
  issn        = "0036-8075, 1095-9203",
  pmid        = "30072512",
  doi         = "10.1126/science.aar7042"
}

@UNPUBLISHED{Amrute2022-wt,
  title    = "Targeting the {Immune-Fibrosis} Axis in Myocardial Infarction and
              Heart Failure",
  author   = "Amrute, Junedh M and Luo, Xin and Penna, Vinay and Bredemeyer,
              Andrea and Yamawaki, Tracy and Heo, Gyu Seong and Shi, Sally and
              Koenig, Andrew and Yang, Steven and Kadyrov, Farid and Jones,
              Cameran and Kuppe, Christoph and Kopecky, Benjamin and Hayat,
              Sikander and Ma, Pan and Feng, Guoshai and Terada, Yuriko and Fu,
              Angela and Furtado, Milena and Kreisel, Daniel and Stitziel,
              Nathan O and Li, Chi-Ming and Kramann, Rafael and Liu, Yongjian
              and Ason, Brandon and Lavine, Kory J",
  abstract = "Cardiac fibrosis is causally linked to heart failure pathogenesis
              and adverse clinical outcomes. However, the precise fibroblast
              populations that drive fibrosis in the human heart and the
              mechanisms that govern their emergence remain incompletely
              defined. Here, we performed Cellular Indexing of Transcriptomes
              and Epitomes by sequencing (CITE-seq) in 22 explanted human
              hearts from healthy donors, acute myocardial infarction (MI), and
              chronic ischemic and non-ischemic cardiomyopathy patients. We
              identified a fibroblast trajectory marked by fibroblast activator
              protein (FAP) and periostin (POSTN) expression that was
              independent of myofibroblasts, peaked early after MI, remained
              elevated in chronic heart failure, and displayed a
              transcriptional signature consistent with fibrotic activity. We
              assessed the applicability of cardiac fibrosis models and
              demonstrated that mouse MI, angiotensin II/phenylephrine
              infusion, and pressure overload models were superior compared to
              cultured human heart and dermal fibroblasts in recapitulating
              cardiac fibroblast diversity including pathogenic cell states.
              Ligand-receptor analysis and spatial transcriptomics predicted
              interactions between macrophages, T cells, and fibroblasts within
              spatially defined niches. CCR2+ monocyte and macrophage states
              were the dominant source of ligands targeting fibroblasts.
              Inhibition of IL-1$\beta$ signaling to cardiac fibroblasts was
              sufficient to suppress fibrosis, emergence, and maturation of
              FAP+POSTN+ fibroblasts. Herein, we identify a human fibroblast
              trajectory marked by FAP and POSTN expression that is associated
              with cardiac fibrosis and identify macrophage-fibroblast
              crosstalk mediated by IL-1$\beta$ signaling as a key regulator of
              pathologic fibroblast differentiation and fibrosis. \#\#\#
              Competing Interest Statement TY, SS, AF, MF, C-ML and BA are or
              were employed by Amgen.",
  journal  = "bioRxiv",
  pages    = "2022.10.17.512579",
  month    =  oct,
  year     =  2022,
  url      = "https://www.biorxiv.org/content/10.1101/2022.10.17.512579v1.supplementary-material",
  keywords = "1\_reading\_list",
  language = "en",
  doi      = "10.1101/2022.10.17.512579"
}

@ARTICLE{Domcke2023-rz,
  title       = "A reference cell tree will serve science better than a
                 reference cell atlas",
  author      = "Domcke, Silvia and Shendure, Jay",
  affiliation = "Department of Genome Sciences, University of Washington School
                 of Medicine, Seattle, WA, USA. Electronic address:
                 domcke@uw.edu. Department of Genome Sciences, University of
                 Washington School of Medicine, Seattle, WA, USA; Brotman Baty
                 Institute for Precision Medicine, Seattle, WA, USA; Allen
                 Discovery Center for Cell Lineage Tracing, Seattle, WA, USA;
                 Howard Hughes Medical Institute, Seattle, WA, USA. Electronic
                 address: shendure@uw.edu.",
  abstract    = "Single-cell biology is facing a crisis of sorts. Vast numbers
                 of single-cell molecular profiles are being generated,
                 clustered and annotated. However, this is overwhelmingly ad
                 hoc, and we continue to lack a principled, unified, and
                 well-moored system for defining, naming, and organizing cell
                 types. In this perspective, we argue against an atlas or
                 periodic table-like discretization as the right metaphor for a
                 reference taxonomy of cell types. In its place, we advocate
                 for a data-driven, tree-based nomenclature that is rooted in a
                 ``consensus ontogeny'' spanning the life cycle of a given
                 species. We explore how such a reference cell tree, inclusive
                 of both lineage histories and molecular states, could be
                 constructed, represented, and segmented in practice. Analogous
                 to the taxonomic classification of species, a consensus
                 ontogeny would provide a universal, stable, and extendable
                 framework for precise scientific communication, both
                 contemporaneously and across the ages.",
  journal     = "Cell",
  volume      =  186,
  number      =  6,
  pages       = "1103--1114",
  month       =  mar,
  year        =  2023,
  url         = "http://dx.doi.org/10.1016/j.cell.2023.02.016",
  keywords    = "1\_reading\_list",
  language    = "en",
  issn        = "0092-8674, 1097-4172",
  pmid        = "36931241",
  doi         = "10.1016/j.cell.2023.02.016"
}

@ARTICLE{Boileau2022-hh,
  title       = "{Full-Length} Spatial Transcriptomics Reveals the Unexplored
                 Isoform Diversity of the Myocardium {Post-MI}",
  author      = "Boileau, Etienne and Li, Xue and Naarmann-de Vries, Isabel S
                 and Becker, Christian and Casper, Ramona and Altm{\"u}ller,
                 Janine and Leuschner, Florian and Dieterich, Christoph",
  affiliation = "Section of Bioinformatics and Systems Cardiology, Klaus
                 Tschira Institute for Integrative Computational Cardiology,
                 Heidelberg, Germany. Department of Internal Medicine III
                 (Cardiology, Angiology, and Pneumology), University Hospital
                 Heidelberg, Heidelberg, Germany. DZHK (German Centre for
                 Cardiovascular Research) Partner Site Heidelberg/Mannheim,
                 Heidelberg, Germany. Cologne Center for Genomics (CCG),
                 University of Cologne, Cologne, Germany. Berlin Institute of
                 Health at Charit{\'e}-Universit{\"a}tsmedizin Berlin, Max
                 Delbr{\"u}ck Center for Molecular Medicine, Berlin, Germany.",
  abstract    = "We introduce Single-cell Nanopore Spatial Transcriptomics
                 (scNaST), a software suite to facilitate the analysis of
                 spatial gene expression from second- and third-generation
                 sequencing, allowing to generate a full-length
                 near-single-cell transcriptional landscape of the tissue
                 microenvironment. Taking advantage of the Visium Spatial
                 platform, we adapted a strategy recently developed to assign
                 barcodes to long-read single-cell sequencing data for spatial
                 capture technology. Here, we demonstrate our workflow using
                 four short axis sections of the mouse heart following
                 myocardial infarction. We constructed a de novo transcriptome
                 using long-read data, and successfully assigned 19,794
                 transcript isoforms in total, including clinically-relevant,
                 but yet uncharacterized modes of transcription, such as intron
                 retention or antisense overlapping transcription. We showed a
                 higher transcriptome complexity in the healthy regions, and
                 identified intron retention as a mode of transcription
                 associated with the infarct area. Our data revealed a clear
                 regional isoform switching among differentially used
                 transcripts for genes involved in cardiac muscle contraction
                 and tissue morphogenesis. Molecular signatures involved in
                 cardiac remodeling integrated with morphological context may
                 support the development of new therapeutics towards the
                 treatment of heart failure and the reduction of cardiac
                 complications.",
  journal     = "Front. Genet.",
  volume      =  13,
  pages       = "912572",
  month       =  jul,
  year        =  2022,
  url         = "http://dx.doi.org/10.3389/fgene.2022.912572",
  keywords    = "myocardial infarction; oxford nanopore technology; single-cell
                 RNA sequencing; spatial transcriptomics; visium
                 spatial;1\_reading\_list",
  language    = "en",
  issn        = "1664-8021",
  pmid        = "35937994",
  doi         = "10.3389/fgene.2022.912572",
  pmc         = "PMC9354982"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@UNPUBLISHED{Sziraki2022-lz,
  title    = "A global view of aging and Alzheimer's pathogenesis-associated
              cell population dynamics and molecular signatures in the human
              and mouse brains",
  author   = "Sziraki, Andras and Lu, Ziyu and Lee, Jasper and Banyai, Gabor
              and Anderson, Sonya and Abdulraouf, Abdulraouf and Metzner, Eli
              and Liao, Andrew and Epstein, Alexander and Xu, Zihan and Zhang,
              Zehao and Gan, Li and Nelson, Peter T and Zhou, Wei and Cao,
              Junyue",
  abstract = "Although several studies have applied single-cell approaches to
              explore gene expression changes in aged brains, they were limited
              by the relatively shallow sampling of brain cell populations, and
              thus may have failed to capture aspects of the molecular
              signatures and dynamics of rare cell types associated with aging
              and diseases. Here, we set out to investigate the age-dependent
              dynamics of transcription and chromatin accessibility across
              diverse brain cell types. With EasySci , an extensively improved
              single-cell combinatorial indexing strategy, we profiled 1.5
              million single-cell transcriptomes and 400,000 single-cell
              chromatin accessibility profiles across mouse brains spanning
              different ages, genotypes, and both sexes. With a novel
              computational framework designed for characterizing cellular
              subtypes based on the expression of both genes and exons, we
              identified > 300 cell subtypes and deciphered the underlying
              molecular programs and spatial locations of rare cell types (
              e.g., pinealocytes, tanycytes) and subtypes. Leveraging these
              data, we generate a global readout of age-dependent cell
              population dynamics with high cellular subtype resolution,
              providing insights into cell types that expand (e.g., rare
              astrocytes and vascular leptomeningeal cells in the olfactory
              bulb, reactive microglia and oligodendrocytes) or are depleted (
              e.g., neuronal progenitors, neuroblasts, committed
              oligodendrocyte precursors) as age progresses. Furthermore, we
              explored cell-type-specific responses to genetic perturbations
              associated with Alzheimer's disease (AD) and identify rare cell
              types depleted ( e.g., mt-Cytb + , mt-Rnr2 + choroid plexus
              epithelial cells) or enriched ( e.g., Col25a1 +, Ndrg1 +
              interbrain and midbrain neurons) in both AD models. Key findings
              are consistent between males and females, validated across the
              transcriptome, chromatin accessibility, and spatial analyses.
              Finally, we profiled a total of 118,240 single-nuclei
              transcriptomes from twenty-four human brain samples derived from
              control and AD patients, revealing highly cell-type-specific and
              region-specific gene expression changes associated with AD
              pathogenesis. Critical AD-associated gene signatures were
              validated in both human and mice. In summary, these data comprise
              a rich resource for exploring cell-type-specific dynamics and the
              underlying molecular mechanisms in both normal and pathological
              mammalian aging. \#\#\# Competing Interest Statement The authors
              have declared no competing interest.",
  journal  = "bioRxiv",
  pages    = "2022.09.28.509825",
  month    =  sep,
  year     =  2022,
  url      = "https://www.biorxiv.org/content/10.1101/2022.09.28.509825v1?rss=1&s=03",
  keywords = "1\_reading\_list;Single-cell",
  language = "en",
  doi      = "10.1101/2022.09.28.509825"
}

@ARTICLE{Pinto2012-ci,
  title       = "An abundant tissue macrophage population in the adult murine
                 heart with a distinct alternatively-activated macrophage
                 profile",
  author      = "Pinto, Alexander R and Paolicelli, Rosa and Salimova,
                 Ekaterina and Gospocic, Janko and Slonimsky, Esfir and
                 Bilbao-Cortes, Daniel and Godwin, James W and Rosenthal, Nadia
                 A",
  affiliation = "European Molecular Biology Laboratory, Mouse Biology Unit,
                 Monterotondo, Rome, Italy. alex.pinto@monash.edu",
  abstract    = "Cardiac tissue macrophages (cTMs) are a previously
                 uncharacterised cell type that we have identified and
                 characterise here as an abundant GFP(+) population within the
                 adult Cx(3)cr1(GFP/+) knock-in mouse heart. They comprise the
                 predominant myeloid cell population in the myocardium, and are
                 found throughout myocardial interstitial spaces interacting
                 directly with capillary endothelial cells and cardiomyocytes.
                 Flow cytometry-based immunophenotyping shows that cTMs exhibit
                 canonical macrophage markers. Gene expression analysis shows
                 that cTMs (CD45(+)CD11b(+)GFP(+)) are distinct from
                 mononuclear CD45(+)CD11b(+)GFP(+) cells sorted from the spleen
                 and brain of adult Cx(3)cr1(GFP/+) mice. Gene expression
                 profiling reveals that cTMs closely resemble
                 alternatively-activated anti-inflammatory M2 macrophages,
                 expressing a number of M2 markers, including Mrc1, CD163, and
                 Lyve-1. While cTMs perform normal tissue macrophage
                 homeostatic functions, they also exhibit a distinct phenotype,
                 involving secretion of salutary factors (including IGF-1) and
                 immune modulation. In summary, the characterisation of cTMs at
                 the cellular and molecular level defines a potentially
                 important role for these cells in cardiac homeostasis.",
  journal     = "PLoS One",
  volume      =  7,
  number      =  5,
  pages       = "e36814",
  month       =  may,
  year        =  2012,
  url         = "http://dx.doi.org/10.1371/journal.pone.0036814",
  keywords    = "1\_reading\_list",
  language    = "en",
  issn        = "1932-6203",
  pmid        = "22590615",
  doi         = "10.1371/journal.pone.0036814",
  pmc         = "PMC3349649"
}

@ARTICLE{Grancharova2021-iy,
  title       = "A comprehensive analysis of gene expression changes in a high
                 replicate and open-source dataset of differentiating
                 {hiPSC-derived} cardiomyocytes",
  author      = "Grancharova, Tanya and Gerbin, Kaytlyn A and Rosenberg,
                 Alexander B and Roco, Charles M and Arakaki, Joy E and DeLizo,
                 Colette M and Dinh, Stephanie Q and Donovan-Maiye, Rory M and
                 Hirano, Matthew and Nelson, Angelique M and Tang, Joyce and
                 Theriot, Julie A and Yan, Calysta and Menon, Vilas and
                 Palecek, Sean P and Seelig, Georg and Gunawardane, Ruwanthi N",
  affiliation = "Allen Institute for Cell Science, Seattle, WA, USA. Department
                 of Electrical \& Computer Engineering, University of
                 Washington, Seattle, WA, USA. , Parse Biosciences, Seattle,
                 WA, USA. Department of Bioengineering, University of
                 Washington, Seattle, WA, USA. Department of Biology, Howard
                 Hughes Medical Institute, University of Washington, Seattle,
                 WA, USA. Department of Neurology, Columbia University Irving
                 Medical Center, New York, NY, USA. Department of Chemical and
                 Biological Engineering, University of Wisconsin - Madison,
                 Madison, WI, USA. Paul G. Allen School of Computer Science and
                 Engineering, University of Washington, Seattle, WA, USA. Allen
                 Institute for Cell Science, Seattle, WA, USA.
                 rug@alleninstitute.org.",
  abstract    = "We performed a comprehensive analysis of the transcriptional
                 changes occurring during human induced pluripotent stem cell
                 (hiPSC) differentiation to cardiomyocytes. Using single cell
                 RNA-seq, we sequenced > 20,000 single cells from 55
                 independent samples representing two differentiation protocols
                 and multiple hiPSC lines. Samples included experimental
                 replicates ranging from undifferentiated hiPSCs to mixed
                 populations of cells at D90 post-differentiation.
                 Differentiated cell populations clustered by time point, with
                 differential expression analysis revealing markers of
                 cardiomyocyte differentiation and maturation changing from D12
                 to D90. We next performed a complementary cluster-independent
                 sparse regression analysis to identify and rank genes that
                 best assigned cells to differentiation time points. The two
                 highest ranked genes between D12 and D24 (MYH7 and MYH6)
                 resulted in an accuracy of 0.84, and the three highest ranked
                 genes between D24 and D90 (A2M, H19, IGF2) resulted in an
                 accuracy of 0.94, revealing that low dimensional gene features
                 can identify differentiation or maturation stages in
                 differentiating cardiomyocytes. Expression levels of select
                 genes were validated using RNA FISH. Finally, we interrogated
                 differences in cardiac gene expression resulting from two
                 differentiation protocols, experimental replicates, and three
                 hiPSC lines in the WTC-11 background to identify sources of
                 variation across these experimental variables.",
  journal     = "Sci. Rep.",
  volume      =  11,
  number      =  1,
  pages       = "15845",
  month       =  aug,
  year        =  2021,
  url         = "http://dx.doi.org/10.1038/s41598-021-94732-1",
  keywords    = "1\_reading\_list",
  language    = "en",
  issn        = "2045-2322",
  pmid        = "34349150",
  doi         = "10.1038/s41598-021-94732-1",
  pmc         = "PMC8338992"
}

@ARTICLE{Yamada2022-bb,
  title     = "Spatiotemporal transcriptome analysis reveals critical roles for
               mechano-sensing genes at the border zone in remodeling after
               myocardial infarction",
  author    = "Yamada, Shintaro and Ko, Toshiyuki and Hatsuse, Satoshi and
               Nomura, Seitaro and Zhang, Bo and Dai, Zhehao and Inoue,
               Shunsuke and Kubota, Masayuki and Sawami, Kosuke and Yamada,
               Takanobu and Sassa, Tatsuro and Katagiri, Mikako and Fujita,
               Kanna and Katoh, Manami and Ito, Masamichi and Harada, Mutsuo
               and Toko, Haruhiro and Takeda, Norifumi and Morita, Hiroyuki and
               Aburatani, Hiroyuki and Komuro, Issei",
  abstract  = "The underlying mechanisms of ventricular remodeling after
               myocardial infarction (MI) remain largely unknown. In this
               study, we performed an integrative analysis of spatial
               transcriptomics and single-nucleus RNA sequencing (snRNA-seq) in
               a murine MI model and found that mechanical stress-response
               genes are expressed at the border zone and play a critical role
               in left ventricular remodeling after MI. An integrative analysis
               of snRNA-seq and spatial transcriptome of the heart tissue after
               MI identified the unique cluster that appeared at the border
               zone in an early stage, highly expressing mechano-sensing genes,
               such as Csrp3. AAV9-mediated gene silencing and overexpression
               of Csrp3 demonstrated that upregulation of Csrp3 plays critical
               roles in preventing cardiac remodeling after MI by regulation of
               genes associated with mechano-sensing. Overall, our study not
               only provides an insight into spatiotemporal molecular changes
               after MI but also highlights that the mechano-sensing genes at
               the border zone act as adaptive regulators of left ventricular
               remodeling. Komuro et al. performed an integrative analysis of
               single-nucleus RNA sequncing and spatial transcriptome analysis
               of the injured heart to map cellular and molecular changes
               across topographical domains relative to the site of injury, and
               they identify that mechano-sensing genes at the border zone act
               as adaptive regulators of left ventricular remodeling.",
  journal   = "Nature Cardiovascular Research",
  publisher = "Nature Publishing Group",
  pages     = "1--12",
  month     =  nov,
  year      =  2022,
  url       = "https://www.nature.com/articles/s44161-022-00140-7",
  keywords  = "1\_reading\_list;Myocardial infarction;Single-cell",
  language  = "en",
  issn      = "2731-0590, 2731-0590",
  doi       = "10.1038/s44161-022-00140-7"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Calcagno2022-ts,
  title     = "Single-cell and spatial transcriptomics of the infarcted heart
               define the dynamic onset of the border zone in response to
               mechanical destabilization",
  author    = "Calcagno, D M and Taghdiri, N and Ninh, V K and Mesfin, J M and
               Toomu, A and Sehgal, R and Lee, J and Liang, Y and Duran, J M
               and Adler, E and Christman, K L and Zhang, K and Sheikh, F and
               Fu, Z and King, K R",
  abstract  = "The border zone (BZ) of the infarcted heart is a geographically
               complex and biologically enigmatic interface separating poorly
               perfused infarct zones (IZs) from remote zones (RZs). The
               cellular and molecular mechanisms of myocardial BZs are not well
               understood because microdissection inevitably combines them with
               uncontrolled amounts of RZs and IZs. Here, we use
               single-cell/nucleus RNA sequencing, spatial transcriptomics and
               multiplexed RNA fluorescence in situ hybridization to redefine
               the BZ based on cardiomyocyte transcriptomes. BZ1 (Nppa+Xirp2)
               forms a hundreds-of-micrometer-thick layer of morphologically
               intact cells adjacent to RZs that are detectable within an hour
               of injury. Meanwhile, BZ2 (Nppa+Xirp2+) forms a
               near-single-cell-thick layer of morphologically distorted
               cardiomyocytes at the IZ edge that colocalize with matricellular
               protein-expressing myofibroblasts and express predominantly
               mechanotransduction genes. Surprisingly, mechanical injury alone
               is sufficient to induce BZ genes. We propose a `loss of
               neighbor' hypothesis to explain how ischemic cell death
               mechanically destabilizes the BZ to induce its transcriptional
               response. Using single-cell/single-nucleus RNA sequencing and
               spatial transcriptomic analysis, Calcagno and Taghdiri et al.
               define the ischemic border zone---the area between the poorly
               perfused infarct area and the remote zones of the heart---based
               on the cardiomyocyte transcriptomes. The transcriptional border
               zone emerges within an hour of the ischemic injury and can be
               observed in response to any injury that causes loss of
               neighboring cells and mechanical destabilization, including the
               trauma induced with a fine needle.",
  journal   = "Nature Cardiovascular Research",
  publisher = "Nature Publishing Group",
  pages     = "1--17",
  month     =  nov,
  year      =  2022,
  url       = "https://www.nature.com/articles/s44161-022-00160-3",
  keywords  = "1\_reading\_list;Myocardial infarction;Single-cell;Spatial
               transcriptomics",
  language  = "en",
  issn      = "2731-0590, 2731-0590",
  doi       = "10.1038/s44161-022-00160-3"
}

@ARTICLE{Li_undated-tx,
  title    = "Single-cell transcriptome sequencing of macrophages in common
              cardiovascular diseases",
  author   = "Li, Lanfang and Ma, Qiuxiao and Wang, Min and Mou, Junyu and Han,
              Yanwei and Wang, Jialu and Ye, Jingxue and Sun, Guibo",
  abstract = "Macrophages associated with various cardiovascular diseases are
              heterogeneous. Single-cell RNA-sequencing provides important and
              new insights into the role of m",
  journal  = "J. Leukoc. Biol.",
  url      = "https://academic.oup.com/jleukbio/advance-article-pdf/doi/10.1093/jleuko/qiac014/48722983/qiac014.pdf",
  keywords = "1\_reading\_list",
  issn     = "0741-5400",
  doi      = "10.1093/jleuko/qiac014"
}

@ARTICLE{Li2022-fe,
  title       = "{DISCO}: a database of Deeply Integrated human {Single-Cell}
                 Omics data",
  author      = "Li, Mengwei and Zhang, Xiaomeng and Ang, Kok Siong and Ling,
                 Jingjing and Sethi, Raman and Lee, Nicole Yee Shin and
                 Ginhoux, Florent and Chen, Jinmiao",
  affiliation = "Singapore Immunology Network (SIgN), Agency for Science,
                 Technology and Research (A*STAR), 8A Biomedical Grove, Immunos
                 Building, Level 3, Singapore 138648, Singapore. Shanghai
                 Institute of Immunology, Shanghai JiaoTong University School
                 of Medicine, Shanghai 200025, China. Translational Immunology
                 Institute, SingHealth Duke-NUS Academic Medical Centre,
                 Singapore 169856, Singapore. Immunology Translational Research
                 Program, Yong Loo Lin School of Medicine, Department of
                 Microbiology and Immunology, National University of Singapore
                 (NUS), 5 Science Drive 2, Blk MD4, Level 3, Singapore 117545,
                 Singapore.",
  abstract    = "The ability to study cellular heterogeneity at single cell
                 resolution is making single-cell sequencing increasingly
                 popular. However, there is no publicly available resource that
                 offers an integrated cell atlas with harmonized metadata that
                 users can integrate new data with. Here, we present DISCO
                 (https://www.immunesinglecell.org/), a database of Deeply
                 Integrated Single-Cell Omics data. The current release of
                 DISCO integrates more than 18 million cells from 4593 samples,
                 covering 107 tissues/cell lines/organoids, 158 diseases, and
                 20 platforms. We standardized the associated metadata with a
                 controlled vocabulary and ontology system. To allow large
                 scale integration of single-cell data, we developed
                 FastIntegration, a fast and high-capacity version of Seurat
                 Integration. We also developed CELLiD, an atlas guided
                 automatic cell type identification tool. Employing these two
                 tools on the assembled data, we constructed one global atlas
                 and 27 sub-atlases for different tissues, diseases, and cell
                 types. DISCO provides three online tools, namely Online
                 FastIntegration, Online CELLiD, and CellMapper, for users to
                 integrate, annotate, and project uploaded single-cell RNA-seq
                 data onto a selected atlas. Collectively, DISCO is a versatile
                 platform for users to explore published single-cell data and
                 efficiently perform integrated analysis with their own data.",
  journal     = "Nucleic Acids Res.",
  volume      =  50,
  number      = "D1",
  pages       = "D596--D602",
  month       =  jan,
  year        =  2022,
  url         = "http://dx.doi.org/10.1093/nar/gkab1020",
  keywords    = "1\_reading\_list",
  language    = "en",
  issn        = "0305-1048, 1362-4962",
  pmid        = "34791375",
  doi         = "10.1093/nar/gkab1020",
  pmc         = "PMC8728243"
}

@ARTICLE{Pfaendler_undated-dy,
  title    = "Self-supervised vision transformers accurately decode cellular
              state heterogeneity",
  author   = "Pfaendler, Ramon and Hanimann, Jacob and Lee, Sohyon and Snijder,
              Berend",
  url      = "http://dx.doi.org/10.1101/2023.01.16.524226",
  keywords = "1\_reading\_list",
  doi      = "10.1101/2023.01.16.524226"
}

@UNPUBLISHED{Ramirez_Flores2023-nk,
  title    = "Multicellular factor analysis of single-cell data for a
              tissue-centric understanding of disease",
  author   = "Ramirez Flores, Ricardo O and Lanzer, Jan D and Dimitrov, Daniel
              and Velten, Britta and Saez-Rodriguez, Julio",
  abstract = "Single-cell atlases across conditions are essential in the
              characterization of human disease. In these complex experimental
              designs, patient samples are profiled across distinct cell-types
              and clinical conditions to describe disease processes at the
              cellular level. However, most of the current analysis tools are
              limited to pairwise cross-condition comparisons, disregarding the
              multicellular nature of disease processes and the effects of
              other biological and technical factors in the variation of gene
              expression. Here we propose a computational framework for an
              unsupervised analysis of samples from cross-condition single-cell
              atlases and for the identification of multicellular programs
              associated with disease. Our strategy, that repurposes
              multi-omics factor analysis, incorporates the variation of
              patient samples across cell-types and enables the joint analysis
              of multiple patient cohorts, facilitating integration of atlases.
              We applied our analysis to a collection of acute and chronic
              human heart failure single-cell datasets and described
              multicellular processes of cardiac remodeling that were conserved
              in independent spatial and bulk transcriptomics datasets. In sum,
              our framework serves as an exploratory tool for unsupervised
              analysis of cross-condition single-cell atlas and allows for the
              integration of the measurements of patient cohorts across
              distinct data modalities, facilitating the generation of
              comprehensive tissue-centric understanding of disease.
              ![Figure][1] \#\#\# Competing Interest Statement J.S.R. reports
              funding from GSK, Pfizer and Sanofi and fees from Travere
              Therapeutics, and Astex. [1]: pending:yes",
  journal  = "bioRxiv",
  pages    = "2023.02.23.529642",
  month    =  feb,
  year     =  2023,
  url      = "https://www.biorxiv.org/content/10.1101/2023.02.23.529642v1",
  keywords = "1\_reading\_list",
  language = "en",
  doi      = "10.1101/2023.02.23.529642"
}

@ARTICLE{Bhatia2022-mz,
  title       = "Spatial proteomics in three-dimensional intact specimens",
  author      = "Bhatia, Harsharan Singh and Brunner, Andreas-David and
                 {\"O}zt{\"u}rk, Furkan and Kapoor, Saketh and Rong, Zhouyi and
                 Mai, Hongcheng and Thielert, Marvin and Ali, Mayar and
                 Al-Maskari, Rami and Paetzold, Johannes Christian and Kofler,
                 Florian and Todorov, Mihail Ivilinov and Molbay, Muge and
                 Kolabas, Zeynep Ilgin and Negwer, Moritz and Hoeher, Luciano
                 and Steinke, Hanno and Dima, Alina and Gupta, Basavdatta and
                 Kaltenecker, Doris and Caliskan, {\"O}z{\"u}m Sehnaz and
                 Brandt, Daniel and Krahmer, Natalie and M{\"u}ller, Stephan
                 and Lichtenthaler, Stefan Frieder and Hellal, Farida and
                 Bechmann, Ingo and Menze, Bjoern and Theis, Fabian and Mann,
                 Matthias and Ert{\"u}rk, Ali",
  affiliation = "Insititute for Tissue Engineering and Regenerative Medicine
                 (iTERM), Helmholtz Zentrum M{\"u}nchen, 85764 Neuherberg,
                 Germany; Institute for Stroke and Dementia Research, Klinikum
                 der Universit{\"a}t M{\"u}nchen, Ludwig-Maximilians University
                 Munich, 81377 Munich, Germany. Department for Proteomics and
                 Signal Transduction, Max Planck Institute of Biochemistry,
                 82152 Martinsried, Germany; Boehringer Ingelheim Pharma GmbH
                 \& Co. KG, Drug Discovery Sciences, Birkendorfer Str. 65,
                 D-88400 Biberach Riss, Germany. Insititute for Tissue
                 Engineering and Regenerative Medicine (iTERM), Helmholtz
                 Zentrum M{\"u}nchen, 85764 Neuherberg, Germany. Insititute for
                 Tissue Engineering and Regenerative Medicine (iTERM),
                 Helmholtz Zentrum M{\"u}nchen, 85764 Neuherberg, Germany;
                 Institute for Stroke and Dementia Research, Klinikum der
                 Universit{\"a}t M{\"u}nchen, Ludwig-Maximilians University
                 Munich, 81377 Munich, Germany; Munich Medical Research School
                 (MMRS), 80336 Munich, Germany. Department for Proteomics and
                 Signal Transduction, Max Planck Institute of Biochemistry,
                 82152 Martinsried, Germany. Insititute for Tissue Engineering
                 and Regenerative Medicine (iTERM), Helmholtz Zentrum
                 M{\"u}nchen, 85764 Neuherberg, Germany; Graduate School of
                 Neuroscience (GSN), 82152 Munich, Germany. Institute for
                 Stroke and Dementia Research, Klinikum der Universit{\"a}t
                 M{\"u}nchen, Ludwig-Maximilians University Munich, 81377
                 Munich, Germany; Center for Translational Cancer Research
                 (TranslaTUM) of the TUM, 81675 Munich, Germany; Image-Based
                 Biomedical Modeling, Department of Informatics, Technical
                 University of Munich, 85748 Garching, Germany. Insititute for
                 Tissue Engineering and Regenerative Medicine (iTERM),
                 Helmholtz Zentrum M{\"u}nchen, 85764 Neuherberg, Germany;
                 Center for Translational Cancer Research (TranslaTUM) of the
                 TUM, 81675 Munich, Germany; Image-Based Biomedical Modeling,
                 Department of Informatics, Technical University of Munich,
                 85748 Garching, Germany; Biomedical Image Analysis Group,
                 Department of Computing, Imperial College London, London SW7
                 2AZ, UK. Center for Translational Cancer Research (TranslaTUM)
                 of the TUM, 81675 Munich, Germany; Image-Based Biomedical
                 Modeling, Department of Informatics, Technical University of
                 Munich, 85748 Garching, Germany; Helmholtz AI, Helmholtz
                 Zentrum M{\"u}nchen, 85764 Neuherberg, Germany; Department of
                 Neuroradiology, Klinikum rechts der Isar, 81675 Munich,
                 Germany. Insititute for Tissue Engineering and Regenerative
                 Medicine (iTERM), Helmholtz Zentrum M{\"u}nchen, 85764
                 Neuherberg, Germany; Institute for Stroke and Dementia
                 Research, Klinikum der Universit{\"a}t M{\"u}nchen,
                 Ludwig-Maximilians University Munich, 81377 Munich, Germany;
                 Graduate School of Neuroscience (GSN), 82152 Munich, Germany.
                 Institute of Anatomy, University of Leipzig, 04109 Leipzig,
                 Germany. Center for Translational Cancer Research (TranslaTUM)
                 of the TUM, 81675 Munich, Germany; Image-Based Biomedical
                 Modeling, Department of Informatics, Technical University of
                 Munich, 85748 Garching, Germany. Institute for Stroke and
                 Dementia Research, Klinikum der Universit{\"a}t M{\"u}nchen,
                 Ludwig-Maximilians University Munich, 81377 Munich, Germany;
                 Institute for Diabetes and Cancer, Helmholz Zentrum
                 M{\"u}nchen, 85764 Neuherberg, Germany. Institute for Diabetes
                 and Obesity, Helmholz Zentrum M{\"u}nchen, 85764 Neuherberg,
                 Germany; German Center for Diabetes Research, Helmholz Zentrum
                 M{\"u}nchen, 85764 Neuherberg, Germany. German Center for
                 Neurodegenerative Diseases (DZNE), 81377 Munich, Germany;
                 Neuroproteomics, School of Medicine, Klinikum Rechts der Isar,
                 Technical University of Munich, 81675 Munich, Germany.
                 Graduate School of Neuroscience (GSN), 82152 Munich, Germany;
                 Munich Cluster for Systems Neurology (SyNergy), 81377 Munich,
                 Germany; German Center for Neurodegenerative Diseases (DZNE),
                 81377 Munich, Germany; Neuroproteomics, School of Medicine,
                 Klinikum Rechts der Isar, Technical University of Munich,
                 81675 Munich, Germany. Center for Translational Cancer
                 Research (TranslaTUM) of the TUM, 81675 Munich, Germany;
                 Image-Based Biomedical Modeling, Department of Informatics,
                 Technical University of Munich, 85748 Garching, Germany;
                 Department for Quantitative Biomedicine, University of Zurich,
                 8006 Zurich, Switzerland. Institute of Computational Biology,
                 Helmholz Zentrum M{\"u}nchen, 85764 Neuherberg, Germany; TUM
                 School of Life Sciences Weihenstephan, Technical University of
                 Munich, 85354 Freising, Germany; Department of Mathematics,
                 Technical University of Munich, 85748 Garching, Germany.
                 Department for Proteomics and Signal Transduction, Max Planck
                 Institute of Biochemistry, 82152 Martinsried, Germany; NNF
                 Center for Protein Research, Faculty of Health Sciences,
                 University of Copenhagen, 2200 Copenhagen, Denmark. Electronic
                 address: mmann@biochem.mpg.de. Insititute for Tissue
                 Engineering and Regenerative Medicine (iTERM), Helmholtz
                 Zentrum M{\"u}nchen, 85764 Neuherberg, Germany; Institute for
                 Stroke and Dementia Research, Klinikum der Universit{\"a}t
                 M{\"u}nchen, Ludwig-Maximilians University Munich, 81377
                 Munich, Germany; Graduate School of Neuroscience (GSN), 82152
                 Munich, Germany; Munich Cluster for Systems Neurology
                 (SyNergy), 81377 Munich, Germany. Electronic address:
                 erturk@helmholtz-muenchen.de.",
  abstract    = "Spatial molecular profiling of complex tissues is essential to
                 investigate cellular function in physiological and
                 pathological states. However, methods for molecular analysis
                 of large biological specimens imaged in 3D are lacking. Here,
                 we present DISCO-MS, a technology that combines
                 whole-organ/whole-organism clearing and imaging,
                 deep-learning-based image analysis, robotic tissue extraction,
                 and ultra-high-sensitivity mass spectrometry. DISCO-MS yielded
                 proteome data indistinguishable from uncleared samples in both
                 rodent and human tissues. We used DISCO-MS to investigate
                 microglia activation along axonal tracts after brain injury
                 and characterized early- and late-stage individual
                 amyloid-beta plaques in a mouse model of Alzheimer's disease.
                 DISCO-bot robotic sample extraction enabled us to study the
                 regional heterogeneity of immune cells in intact mouse bodies
                 and aortic plaques in a complete human heart. DISCO-MS enables
                 unbiased proteome analysis of preclinical and clinical tissues
                 after unbiased imaging of entire specimens in 3D, identifying
                 diagnostic and therapeutic opportunities for complex diseases.
                 VIDEO ABSTRACT.",
  journal     = "Cell",
  volume      =  185,
  number      =  26,
  pages       = "5040--5058.e19",
  month       =  dec,
  year        =  2022,
  url         = "http://dx.doi.org/10.1016/j.cell.2022.11.021",
  keywords    = "AI; Alzheimer's; TBI; deep learning; human heart; mass
                 spectrometry; proteomics; robotics; spatial-omics; tissue
                 clearing;1\_reading\_list",
  language    = "en",
  issn        = "0092-8674, 1097-4172",
  pmid        = "36563667",
  doi         = "10.1016/j.cell.2022.11.021"
}
